Evaluation of prescription practices in rheumatoid arthritis at the rheumatology clinic in a tertiary care teaching hospital in Uttarakhand: A cross-sectional study

Evaluation of prescription practices in rheumatoid arthritis at the rheumatology clinic in a tertiary care teaching hospital in Uttarakhand: A cross-sectional study

Objective: This study was aimed to analyze the prescription pattern of disease modifying anti-rheumatic drug (DMARD) therapy in patients with rheumatoid arthritis (RA) in a tertiary care teaching hospital in Uttarakhand, India. Methodology: This cross-sectional study was conducted in 150 RA patients...

Full description

Bibliographic Details
Main Authors:	Gauri Mittal, Manisha Bisht, Venkatesh S Pai, Shailendra S Handu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	cam complimentary alternative medicine therapy disease modifying anti-rheumatic drug (dmards) drug utilization study in ra prescription pattern ra rheumatoid arthritis therapy
Online Access:	http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=2;spage=745;epage=751;aulast=Mittal

Similar Items

Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
by: Hiroki Tawaratsumida, et al.
Published: (2017-12-01)

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment
by: Michael Schiff, et al.
Published: (2017-09-01)

Validity of Doppler subclinical synovitis as an activity marker associated with bone erosions in rheumatoid arthritis patients during clinical remission
by: Tohamy Elkhouly, et al.
Published: (2016-09-01)

Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled
by: Shin-ya Kawashiri, et al.
Published: (2017-05-01)

Predictors and causes of first-line biologic agent discontinuation in rheumatoid arthritis: data from Reuma.pt
by: Joao Lagoas Gomes, et al.
Published: (2019-01-01)

Editor’s Pick: JAK Inhibitors in the Treatment Algorithm of Rheumatoid Arthritis: A Review
by: Salvatore Bellinvia, et al.
Published: (2018-07-01)

Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs
by: Hiroto Tokumoto, et al.
Published: (2018-02-01)

The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
by: Soo-Kyung Cho, et al.
Published: (2017-12-01)

Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?
by: Raimon Sanmartí, et al.
Published: (2021-03-01)

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
by: Dimitrios Vassilopoulos, et al.
Published: (2020-01-01)

Editorial: New Therapies in the Field of Rheumatology
by: Cecilia Beatrice Chighizola, et al.
Published: (2020-01-01)

Statistical Information Included in Labeling for Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis
by: Hatch, Lashley
Published: (2012)

Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis
by: Hiroko Hashimoto, et al.
Published: (2021-10-01)

Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
by: Thomas Wilke, et al.
Published: (2017-08-01)

Pregnancy in Chronic Arthritis: Only a Matter of Planning
by: aloma Vela
Published: (2015-06-01)

A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis
by: Federica Ciregia, et al.
Published: (2021-08-01)

Precision Medicine for Rheumatoid Arthritis: The Right Drug for the Right Patient—Companion Diagnostics
by: Richard Thomas Meehan, et al.
Published: (2021-07-01)

Usefulness of Cytokine Gene Polymorphisms for the Therapeutic Choice in Japanese Patients with Rheumatoid Arthritis
by: Tsujimoto S, et al.
Published: (2021-01-01)

Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial
by: Harindu Wijesinghe, et al.
Published: (2017-07-01)

Evaluation of everyday routine changes caused by rheumatoid arthritis (RA). Differences between genders
by: Marta Obrzud, et al.
Published: (2018-04-01)

Editorial: Comorbidity Burden in Rheumatic Diseases
by: Elena Nikiphorou, et al.
Published: (2018-07-01)

The effect of disease modifying drugs on the lung in patients with rheumatoid arthritis
by: Tashfeen Mahmood, et al.
Published: (2016-01-01)

Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators’ Contribution to Arthritis Physiopathology and Future Perspectives
by: Tiago H. Zaninelli, et al.
Published: (2021-09-01)

Disentangling rheumatoid arthritis patients’ implicit and explicit attitudes towards methotrexate
by: Annemiek J Linn, et al.
Published: (2016-08-01)

Positive affect as a predictor of adherence in patients with Rheumatoid Arthritis
by: Joana Ramos Rodrigues, et al.
Published: (2019-04-01)

Prescription pattern in patients with rheumatoid arthritis in a teaching tertiary care hospital
by: Akhil Dahiya, et al.
Published: (2016-01-01)

Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
by: Paul Emery, et al.
Published: (2020-05-01)

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
by: Yusuke Miyazaki, et al.
Published: (2021-06-01)

Prevalence, impact and care of foot problems in people with rheumatoid arthritis: results from a United Kingdom based cross-sectional survey
by: Oonagh Wilson, et al.
Published: (2017-10-01)

Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
by: Müller S, et al.
Published: (2017-07-01)

Editorial: Traditional Medicine and Rheumatology
by: Zhihua Yang, et al.
Published: (2021-06-01)

Evaluation of Rheumatoid Factor using ELISA versus Latex method: a cross sectional study
by: Khalvat A, et al.
Published: (2008-05-01)

Methotrexate and The Lung in Rheumatoid Arthritis
by: Shamma Ahmad Al Nokhatha, et al.
Published: (2020-07-01)

Statistical Information Included in Labeling for Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis
by: Hatch, Lashley, et al.
Published: (2012)

CLINICAL-LABORATORY REMISSION IN A PATIENT WITH RHEUMATOID ARTHRITIS AFTER APPLICATION OF SYNCHRONIC PROGRAM INTENSIVE THERAPY (SPIT)
by: E A Aseyeva, et al.
Published: (2001-04-01)

Superficial Ulcerating Rheumatoid Necrobiosis Associated with Methotrexate Use in a Patient with Rheumatoid Arthritis
by: Austin Cusick, et al.
Published: (2020-09-01)

Alcohol Consumption in Rheumatoid Arthritis: A Path through the Immune System
by: Vugar Azizov, et al.
Published: (2021-04-01)

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
by: Giulia Cassone, et al.
Published: (2020-04-01)

The relationship between anthropometric status and rheumatoid arthritis. Exploring the role of nesfatin and asymmetric dimethylarginine
by: Farnush Naghashian, et al.
Published: (2019-04-01)

DIAGNOSTIC VALUE OF SEROLOGICAL MARKERS OF RHEUMATOID ARTHRITIS
by: Aleksei Leonidovich Maslaynski, et al.
Published: (2012-10-01)